- $147.14m
- $120.18m
- $6.02m
Helius Medical Technologies Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Helius Medical Technologies Inc-On March 21, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Carvana, Vistagen, Shoe Carnival
U.S. STOCKS ON THE MOVE-Warner Music, 89Bio, Ollie's
Helius Medical rises on distribution deal for nerve modulation device
Brief: Helius Medical Technologies And Healthtech Connex Announce Exclusive Distribution Agreement For Portable Neuromodulation Stimulator Device
Helius Medical Technologies Inc reports results for the quarter ended in December - Earnings Summary
Brief: Helius Medical Technologies Inc Reports Fourth Quarter And Full Year 2022 Financial Results
U.S. STOCKS ON THE MOVE-Vertex Pharma, Duluth, Molecular Templates
U.S. STOCKS ON THE MOVE-BJ's Wholesale, FuelCell Energy, Holley
Helius Medical rises on Canadian approval for stroke therapy
Brief: Helius Medical Announces Health Canada Authorization To Market Portable Neuromodulation Stimulator Device For Treatment Of Gait Deficit Due To Mild And Moderate Symptoms From Stroke
Helius Medical Technologies Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Helius Medical Announces Preliminary Results For Q4, Full Year 2022
Brief: Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results
Brief: Helius Medical Technologies Reports Q2 2022 Results
U.S. STOCKS ON THE MOVE-Energy firms, Retail chatter, MoneyGram
U.S. STOCKS ON THE MOVE-Big banks, Beyond Meat, Cinemark
Brief: Helius Medical Technologies Inc Announces Pricing Of $18 Mlon Public Offering